Magnetic Resonance Imaging of Rectal Cancer

ABSTRACT

Magnetic resonance imaging (MRI)is a useful modality for the evaluation of rectal cancer, providing superior anatomic/pathologic visualization when compared with endorectal ultrasound (EUS) and computed tomography (CT). Preoperative MRI is useful for tissue characterization and tumor staging, which determines the surgical approach and need for neoadjuvant/adjuvant therapy. Important prognostic factors include the circumferential resection margin (CRM), T and N stages, and extent of local invasion. Postoperative MRI to assess the extent of tumor recurrence enables early resection, which can greatly prolong survival. MRI criteria for local recurrence include T2 hyperintensity, early dynamic rim enhancement, and nodular morphology. Future research in MRI of rectal cancer is geared toward developing optimal imaging techniques including high-resolution MRI, whole-body scans, and parallel imaging; imaging of lymph nodes by MR lymphography; and response to therapy using diffusion/perfusion-weighted MR and functional imaging.

KEYWORDS

Magnetic resonance - rectal cancer - preoperative - postoperative - recurrence

REFERENCES

• 1 Hussain S M, Outwater E K, Siegelman E S. Mucinous versus nonmucinous rectal carcinomas: differentiation with MR imaging.  Radiology. 1999;  213(1) 79-85
• 2 Beets-Tan R G, Beets G L. Rectal cancer: review with emphasis on MR imaging.  Radiology. 2004;  232(2) 335-346
• 3 Klessen C, Rogalla P, Taupitz M. Local staging of rectal cancer: the current role of MRI.  Eur J Radiol. 2007;  17(2) 379-389
• 4 Iafrate F, Laghi A, Paolantonio P et al.. Preoperative staging of rectal cancer with MR imaging: correlation with surgical and histopathologic findings.  Radiographics. 2006;  26(3) 701-714
• 5 Lahaye M J, Lamers W H, Beets G L, Beets-Tan R GH. MR Anatomy of the rectum and the mesorectum. In: Di Falco G, Santoro GA Benign Anorectal Diseases: Diagnosis with Endoanal and Endorectal Ultrasound and New Treatment Options. New York, NY; Springer 2006: 67-77
• 6 Sahani D V, Kalva S P, Hahn P F. Imaging of rectal cancer.  Semin Radiat Oncol. 2003;  13(4) 389-402
• 7 Dobos N, Rubesin S E. Radiologic imaging modalities in the diagnosis and management of colorectal cancer.  Hematol Oncol Clin North Am. 2002;  16(4) 875-895
• 8 Vliegen R F, Beets G L, von Meyenfeldt M F et al.. Rectal cancer: MR imaging in local staging–is gadolinium-based contrast material helpful?.  Radiology. 2005;  234(1) 179-188
• 9 Wallengren N O, Holtas S, Andren-Sandberg A, Jonsson E, Kristoffersson D T, McGill S. Rectal carcinoma: double-contrast MR imaging for preoperative staging.  Radiology. 2000;  215(1) 108-114
• 10 Elmas N, Killi R M, Sever A, Klessen C, Rogalla P, Taupitz M. Colorectal carcinoma: radiological diagnosis and staging.  Eur J Radiol. 2002;  42(3) 206-223
• 11 Goh V, Halligan S, Bartram C I. Local radiological staging of rectal cancer.  Clin Radiol. 2004;  59(3) 215-226
• 12 Maier A, Fuchsjager M. Preoperative staging of rectal cancer.  Eur J Radiol. 2003;  47(2) 89-97
• 13 Moran B, Brown G, Cunningham D, Daniels I, Heald R, Quirke P, Sebag-Montefiore D. Clarifying the TNM staging of rectal cancer in the context of modern imaging and neo-adjuvant treatment: ‘y' ‘u’ and ‘p’ need ‘mr’ and ‘ct’.  Colorectal Dis. 2008;  10(3) 242-243
• 14 Hoeffel C, Arrivé L, Mourra N, Azizi L, Lewin M, Tubiana J M. Anatomic and pathologic findings at external phased-array pelvic MR imaging after surgery for anorectal disease.  Radiographics. 2006;  26(5) 1391-1407
• 15 Messiou C, Chalmers A, Boyle K, Sagar P. Surgery for recurrent rectal carcinoma: The role of preoperative magnetic resonance imaging.  Clin Radiol. 2006;  61(3) 250-258
• 16 Tan P L, Chan C L, Moore N R. Radiological appearances in the pelvis following rectal cancer surgery.  Clin Radiol. 2005;  60(8) 846-855
• 17 Brown G, Richards C J, Newcombe R G et al.. Rectal carcinoma: thin-section MR imaging for staging in 28 patients.  Radiology. 1999;  211(1) 215-222
• 18 Barrett T, Kobayashi H, Brechbiel M, Choyke P L. Macromolecular MRI contrast agents for imaging tumor angiogenesis.  Eur J Radiol. 2006;  60(3) 353-366
• 19 Zahra M A, Hollingsworth K G, Sala E, Lomas D J, Tan L T. Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy.  Lancet Oncol. 2007;  8(1) 63-74